We have been busy preparing for a number of upcoming conferences in November1.
At the 2nd International Akademie Fresenius Gene-Tox Conference (November 3, 2022), Kevin Cross will discuss “N-Nitrosamine Impurities in Drugs – Introducing the EMA-Mutamind Project”.
As part of the Extractables & Leachables Europe 2022 Conference (November 7 – 8, 2022) Glenn Myatt will make a presentation on ‘Emerging applications of computational methods in the assessment of extractables and leachables”.
In addition, at the American College of Toxicology’s 43rd Annual Meeting (November 13 – 16, 2022), we will be presenting on “Strategic In Silico: Creating Powerful New Scientific Insights” (Tuesday, November 15, 12.00-12.55pm) as well as participating in Symposium 1 “ICH S1B(Rq): New Approaches in the Carcinogenicity Assessment of Pharmaceuticals” (Monday 14th November 9-12pm MST) and Workshop 4 “Addressing the Global Challenge of Nitrosamine Impurities in Pharmaceutical Products” (Monday 14th November, 2-5pm MST).
Please let me know if you are interested in discussing any of these presentations (Glenn Myatt; email@example.com).